Takeda Provides Updates on its Hemophilia Studies at WFH 2020, Reinforcing its Commitment to Putting Patients First and Supporting Personalized Care for People with Bleeding Disorders
− These Data Demonstrate Breadth of Takeda’s Portfolio and Pipeline with Three Hematology Presentations at the Virtual Summit OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited,...